title: [Mitomycin C related complications shouldn't be neglected in the pterygium surgery].
abstract: Mitomycin C (MMC), as it could reduce tissue adhesions and scar formation, has been widely adopted in pterygium surgery to lower the recurrence rate.Upon a certain therapeutic effect obtained, a variety of ocular complications was combined and always occupies a quite long time after MMC application.once occurred, it was tough to cure. Compared to autologous limbal-conjunctival grafts, MMC has no apparent advantage to reduce reoccurrence of pterygium. Therefore, it is advised to abandon the use of MMC in pterygium surgery.
authors.affiliation: Shandong Eye Hospital, Shandong Eye Institute, Jinan 250021, China. Email: weiyunshi@163.com.
authors.forename: Wei-yun
authors.initials: WY
authors.lastname: Shi
authors.affiliation: Shandong Eye Hospital, Shandong Eye Institute, Jinan 250021, China.
authors.forename: Fu-hua
authors.initials: FH
authors.lastname: Wang
mesh_terms: D000075202:Contraindications; D006801:Humans; D016685:Mitomycin / Q000009:adverse effects*; D011183:Postoperative Complications; D011625:Pterygium / Q000601:surgery*
chemical_list: D016685:Mitomycin